Wake up! It’s time for our daily #SHIFT20 Coffee Break.

Every morning, we will post the full day's agenda of topics set to be published in this space. Today's topic is Immunity, with posts scheduled throughout the day.

Like Comment

Welcome to our first Coffee Break of the week. Each morning, we will post our agenda of topics for the day in this space.

Today’s focus will be around immunity. And what better time to talk immunity than during these crazy COVID-19 times. That is why we have dedicated our first article of the day entirely to Immunity Support in the Time of Need. 

Make sure to follow along throughout the day as we talk about the below topics. In addition, we encourage you to ask any questions you may have around alternative protein and our capabilities in the comments section below. One of our experts will be on hand to answer your questions.

Today’s Agenda:

Time

Topic

9:30am CDT

Immunity Support in the time of need
Read about ways to maintain a healthy immune system and how wellness-seeking customers in a post COVID-19 world will be looking for enjoyable ways to support function.

12:00pm CDT

Taking turmeric to the next level with Turmipure Gold
Read about how a single 300mg dose of Naturex’s Turmipure Gold delivers the same amount of curcuminoids to the blood as 1922mg of standard turmeric.

2:30pm CDT

The world’s first wholefood fermented zinc for immune health support
Read about Ultimine Zinc, produced using a patented fermentation process that results in a dried biomass, rich in protein, that naturally encapsulates the zinc - responding to growing demand for mineral ingredients from wholefood sources.

3:30pm CDT

Our daily happy hour!
Join us in the room every day at 4:30 where we will have experts ready to chat with you about our products featured that day.

Click here to join the chat!

 


Follow along and ask you questions in the comments! Our experts are here to answer your questions.

Stephen Collins

Head of Communications, NOAM Flavors, Givaudan

15 Contributions
43 Followers
13 Following

No comments yet.